NCT00207402View on ClinicalTrials.gov

Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin

PHASE4CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

July 31, 2010

Conditions
Hepatitis C
Interventions
DRUG

rosiglitazone

Infergen 15mcg/ d Avandia qd Ribavirin bid

Trial Locations (1)

78234

Brooke Army Medical Center, Fort Sam Houston

Sponsors

Collaborators (1)

InterMune
All Listed Sponsors
collaborator

InterMune

INDUSTRY

lead

Brooke Army Medical Center

FED